91
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Bullous Grover’s Disease in a Chinese Tibetan Adolescent: A Case Report

ORCID Icon, ORCID Icon, , , & ORCID Icon
Pages 1371-1376 | Published online: 17 Jul 2022

References

  • Grover RW. Transient acantholytic dermatosis. Arch Dermatol. 1970;101(4):426–434. doi:10.1001/archderm.1970.04000040048010
  • Gantz M, Butler D, Goldberg M, Ryu J, McCalmont T, Shinkai K. Atypical features and systemic associations in extensive cases of Grover disease: a systematic review. J Am Acad Dermatol. 2017;77(5):952–957.e1. doi:10.1016/j.jaad.2017.06.041
  • Fantini F, Kovacs E, Scarabello A. Unilateral transient acantholytic dermatosis (Grover’s disease) along Blaschko lines. J Am Acad Dermatol. 2002;47(2):319–320. doi:10.1067/mjd.2002.120596
  • Liss WA, Norins AL. Zosteriform transient acantholytic dermatosis. J Am Acad Dermatol. 1993;29(5 Pt 1):797–798. doi:10.1016/s0190-9622(08
  • Brown-Joel ZO, Chung J, Stone MS. Pityriasis rubra pilaris-like eruption in the setting of transient acantholytic dermatosis. JAAD Case Rep. 2019;5(8):733–735. doi:10.1016/j.jdcr.2019.06.025
  • Fernández-Figueras MT, Puig L, Cannata P, et al. Grover disease: a reappraisal of histopathological diagnostic criteria in 120 cases. Am J Dermatopathol. 2010;32(6):541–549. doi:10.1097/DAD.0b013e3181c80cf9
  • Chalet M, Grover R, Ackerman AB. Transient acantholytic dermatosis: a reevaluation. Arch Dermatol. 1977;113(4):431–435. doi:10.1001/archderm.1977.01640040039004
  • Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review. J Dtsch Dermatol Ges. 2020;18(8):826–833. doi:10.1111/ddg.14202
  • Dhitavat J, Fairclough RJ, Hovnanian A, Burge SM. Calcium pumps and keratinocytes: lessons from Darier’s disease and Hailey-Hailey disease. Br J Dermatol. 2004;150(5):821–828. doi:10.1111/j.1365-2133.2004.05904.x
  • Wang Z, Wang Z, Sun L, et al. Whole exome sequencing improves mutation detection in Hailey-Hailey disease. J Dermatol. 2021;48(7):989–992. doi:10.1111/1346-8138.15828
  • Kaddu S, Müllegger RR, Kerl H. Grover’s disease associated with Sarcoptes scabiei. Dermatology. 2001;202(3):252–254. doi:10.1159/000051647
  • Grover RW, Rosenbaum R. The association of transient acantholytic dermatosis with other skin diseases. J Am Acad Dermatol. 1984;11(2 Pt 1):253–256. doi:10.1016/s0190-9622(84
  • Guana AL, Cohen PR. Transient acantholytic dermatosis in oncology patients. J Clin Oncol. 1994;12(8):1703–1709. doi:10.1200/jco.1994.12.8.1703
  • Matar S, Oulès B, Sohier P, et al. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature. J Eur Acad Dermatol Venereol. 2020;34(11):e686–e689. doi:10.1111/jdv.16775
  • Beele H, Smet S, Van Damme N, Beeckman D. Incontinence-Associated Dermatitis: pathogenesis, Contributing Factors, Prevention and Management Options. Drugs Aging. 2018;35(1):1–10. doi:10.1007/s40266-017-0507-1
  • Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100. J Clin Microbiol. 2021;59(12):e0021321. doi:10.1128/jcm.00213-21
  • Oliveira D, Borges A, Simões M. Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases. Toxins. 2018;10(6):548. doi:10.3390/toxins10060252
  • Aldana PC, Khachemoune A. Grover disease: review of subtypes with a focus on management options. Int J Dermatol. 2020;59(5):543–550. doi:10.1111/ijd.14700
  • Vivehanantha S, Carr RA, McGrath JA, Taibjee SM, Madhogaria S, Ilchyshyn A. Epidermolysis Bullosa Pruriginosa: a Case With Prominent Histopathologic Inflammation. JAMA Dermatology. 2013;149(6):727–731. doi:10.1001/jamadermatol.2013.155
  • Kalb RE, Strober B, Weinstein G, Lebwohl M. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol. 2009;60(5):824–837. doi:10.1016/j.jaad.2008.11.906
  • Haghi-Aminjan H, Asghari MH, Goharbari MH, Abdollahi M. A systematic review on potential mechanisms of minocycline in kidney diseases. Pharmacol Rep. 2017;69(4):602–609. doi:10.1016/j.pharep.2017.02.001
  • Janakiraman K, Krishnaswami V, Sethuraman V, Natesan S, Rajendran V, Kandasamy R. Development of Methotrexate and Minocycline-Loaded Nanoparticles for the Effective Treatment of Rheumatoid Arthritis. AAPS PharmSciTech. 2020;21(2):34. doi:10.1208/s12249-019-1581-y